Switch to:
More From Other Websites
BioMarin (BMRN) Q4 Earnings: Will it Post a Beat Again? Feb 17 2017
BioMarin Announces 11 Presentations at 13th Annual WORLDSymposium™ 2017 Feb 15 2017
Gilead Sciences & Bristol Myers: Two Wrongs Make a Right? Feb 08 2017
BioMarin to Attend Three Investor Conferences in 1Q17 Feb 08 2017
Your Guide To 2017's Emerging Pharmaceuticals Catalysts Feb 07 2017
BioMarin sues to stop generic version of its $90K-a-year drug Feb 07 2017
BioMarin to Host Fourth Quarter and Full Year 2016 Financial Results Conference Call and Webcast on... Feb 07 2017
Coverage initiated on BioMarin Pharm by Morgan Stanley Feb 07 2017
BioMarin's Hemophilia Candidate Included in PRIME Initiative Feb 02 2017
BioMarin Receives Access to Priority Medicines (PRIME) Regulatory Support from EMA for BMN 270 Gene... Feb 01 2017
4 Top Biotech Stocks With Big Upcoming Catalysts Jan 31 2017
BioMarin Pharmaceutical, Inc. breached its 50 day moving average in a Bullish Manner : BMRN-US :... Jan 30 2017
Is BioMarin (BMRN) Well Poised for Growth in 2017? Jan 26 2017
We’re in the year of the biotech buyout, and here are five prime targets Jan 23 2017
Baird Has 4 Red-Hot Biotechs to Buy for 2017 With Huge Upside Potential Jan 19 2017
BioMarin Pharmaceutical, Inc. breached its 50 day moving average in a Bearish Manner : BMRN-US :... Jan 18 2017
BioMarin CEO: Positive results for hemophilia treatment Jan 09 2017
BioMarin Pharma cites positive results for hemophilia treatment Jan 08 2017
BioMarin to Provide Update to Proof-of-Concept Data for BMN 270 Gene Therapy in Hemophilia A at 35th... Jan 08 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK